Validation of a Prescreening Program for Transcatheter Atrial Septal Defect Closure

George T Nicholson1, Robert N Vincent, Christopher J Petit

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Children's Healthcare of Atlanta/Emory University School of Medicine, 1405 Clifton Road, NE, Atlanta, GA, 30322-1062, USA.

Pediatric Cardiology
|March 21, 2015
PubMed

Insights

Implementing a prescreening protocol for atrial septal defect (ASD) device closure significantly reduced unsuccessful procedures. This evaluation ensures patient suitability and improves family counseling for ASD treatment.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • A significant percentage of patients referred for atrial septal defect (ASD) device closure had anatomy precluding the procedure, leading to workflow inefficiencies.
  • This highlights the need for a structured prescreening process to optimize patient selection and resource allocation.

Purpose of the Study:

  • To evaluate the effectiveness of a comprehensive prescreening protocol for pediatric patients undergoing atrial septal defect (ASD) device closure.
  • To assess the impact of this protocol on procedural success rates, patient selection, and family counseling.

Main Methods:

  • Retrospective study of pediatric patients undergoing ASD prescreening, including transthoracic echocardiogram and family consultation.
  • Analysis of data from January 2011 to June 2013 at Children's Healthcare of Atlanta.
  • Comparison of outcomes before and after implementation of the formal prescreening process.

Main Results:

  • The prescreening protocol identified 29% of patients as unsuitable for device closure.
  • Successful transcutaneous ASD device closure was achieved in 56.5% of screened patients.
  • The incidence of unsuccessful ASD device closure decreased from 30% to 10.3% after implementing the prescreening program.

Conclusions:

  • A comprehensive ASD prescreening evaluation and family consultation process improves the likelihood of successful device implantation.
  • This protocol enhances patient selection, reduces procedural failures, and facilitates adequate preprocedural counseling.
  • Implementing a prescreening program is crucial for optimizing the management of atrial septal defects requiring device closure.